Ligand Pharmaceuticals Incorporated (LGND) Debt to Equity Ratio
Ligand Pharmaceuticals Incorporated (LGND) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2015-12-31 | 0.74 |
| 2016-12-31 | 0.68 |
| 2017-12-31 | 0.63 |
| 2018-12-31 | 1.25 |
| 2019-12-31 | 0.95 |
| 2020-12-31 | 0.92 |
| 2021-12-31 | 0.58 |
| 2022-12-31 | 0.28 |
| 2023-12-31 | 0.12 |
| 2024-12-31 | 0.13 |
Get Ligand Pharmaceuticals Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("LGND", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LGND | $199.59 | +0.00% | 0.22M |
| 3 | ||||
| 4 | ||||
| 5 |